Alterations in KP metabolism has been implicated in a range of CNS disorders including depression [193], bipolar disorder [194–196], schizophrenia [197], neurodegenerative disease [197] and sleep disturbances [198]. This evidence concerns the gene NPPA and major depressive disorder.